PCN57 Cost-Effectiveness of Venetoclax in Combination with Obinutuzumab in First LINE Chronic Lymphocytic Leukemia in Colombia
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.149
https://www.valueinhealthjournal.com/article/S1098-3015(21)00366-1/fulltext
Title :
PCN57 Cost-Effectiveness of Venetoclax in Combination with Obinutuzumab in First LINE Chronic Lymphocytic Leukemia in Colombia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00366-1&doi=10.1016/j.jval.2021.04.149
First page :
Section Title :
Open access? :
No
Section Order :
10724